Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130 A Para. 8 Sgb V With The Active Ingredient Adalimumab 2026-11-10
Germany Abschluss Nicht-exklusiver Rabattvereinbarungen Nach § 130 A Abs. 8 Sgb V Mit Dem Wirkstoff Adalimumab 2026-11-10
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130 A Para. 8 Sgb V With The Active Ingredient Doxylamine 6.96 Mg / Pyridoxine 8.23 ??mg Hvw (cariban) 2026-11-10
Germany Conclusion Of Non-exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Doxylamine 6.96 Mg / Pyridoxine 8.23 ??mg Hvw (cariban) 2026-11-10
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130 A Para. 8 Sgb V In The Period From 01.01.2025 31.12.2026 2026-11-10
Germany Conclusion Of Non-exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Levetiracetam In The Dosage Form Gra. 2026-11-10
Germany Conclusion Of Non-exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Pentoxifylline. 2026-11-10
Germany Conclusion Of Non-exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Cetirizine In The Dosage Forms Tro And Tei. 2026-11-10
Germany Conclusion Of Non-exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Pamidronic Acid. 2026-11-10
Germany Conclusion Of Non-exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Benazepril + Hct (fta) 2026-11-10
Whats app